Spontaneous rosetting characteristics of prostaglandin (PG)-treated lymphocytes from patients with solid neoplasias
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 18 (1) , 85-94
- https://doi.org/10.1016/0090-1229(81)90011-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effect of prostaglandins on mouse erythrocyte rosette-forming human lymphocytesImmunopharmacology, 1980
- Production of prostaglandin E2 by bladder tumor cells in tissue culture and a possible mechanism of lymphocyte inhibitionCellular Immunology, 1979
- T-cell markers in breast cancer patients at diagnosisClinical Immunology and Immunopathology, 1979
- A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cellsCellular Immunology, 1978
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.The Journal of Experimental Medicine, 1977
- Prostaglandins and the immune responseLife Sciences, 1977
- SUBVERSIVE ACTIVITY OF SYNGENEIC TUMOR CELLS AS AN ESCAPE MECHANISM FROM IMMUNE SURVEILLANCE AND THE ROLE OF PROSTAGLANDINSAnnals of the New York Academy of Sciences, 1976
- Control of lymphokine secretion by prostaglandinsNature, 1976
- Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other DiseasesJournal of Clinical Investigation, 1973